Drug Profile
Research programme: ROR gamma receptor modulators - Escalier Biosciences
Alternative Names: Research programme: ROR modulators - Escalier Biosciences; Research programme: RORγt modulators - Escalier Biosciences; ROR-gamma modulators - Escalier Biosciences; RORγ modulators - EscalierLatest Information Update: 28 Apr 2022
Price :
$50
*
At a glance
- Originator Escalier Biosciences
- Class Antipsoriatics; Small molecules
- Mechanism of Action Nuclear receptor subfamily 1 group F member 3 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders; Psoriasis
Most Recent Events
- 28 Apr 2022 No recent reports of development identified for preclinical development in Autoimmune-disorders in Netherlands (PO)
- 28 Apr 2022 No recent reports of development identified for preclinical development in Autoimmune-disorders in Netherlands (Topical)
- 28 Apr 2022 No recent reports of development identified for preclinical development in Autoimmune-disorders in USA (PO)